• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO MEDICAL CORPORATION CAPIOX CUSTOM PACK; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO MEDICAL CORPORATION CAPIOX CUSTOM PACK; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number N/A
Device Problem Obstruction of Flow (2423)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/22/2023
Event Type  malfunction  
Manufacturer Narrative
A1: patient identifier: requested, not provided.A2: age & date of birth: requested, not provided.A3: patient sex: requested, not provided.A4: weight: requested, not provided.A5: ethnicity: requested, not provided.A6: race: requested, not provided.D4: udi no: n/a as this product code is not exported to the us market.D6a: implanted date: device was not implanted.D6b: explanted date: device was not explanted.E3: occupation: clinical engineer.G4: 510(k) no: k071494, k130520.Inspection of the actual sample: 1: the actual sample in the state as received was subjected to visual inspection, and no breakage was found in it.2: the reservoir of the actual sample was disassembled and subjected to visual inspection.There was no damage that could lead to decreasing venous blood flow rate in the venous inlet drop tube inside the defoamer of the venous filter.[?] there was no formation of blood clots that could lead to decreasing venous blood flow rate in the defoamer of the venous filter.Formation of blood clots was observed in the cr filter.3: the oxygenator was filled with glutaraldehyde-containing normal saline and fixed, then the oxygenation module was separated from the housing and filter and inspected visually.No anomaly was found in the condition of fiber winding.4: the oxygenation module was inspected visually while the fiber layer was removed gradually.[?] formation of blood clots was observed.No anomaly was found in the condition of fiber winding.5: the heat exchanger was removed from the outer cylinder and subjected to visual and magnifying inspections.No deformation that could lead to an obstruction was found in the heat exchanger.Record review: review of the manufacturing record and the shipping inspection record of the actual sample found no anomaly.Review of the past complaint file found no other similar report on the involved product code/lot#.Cause of occurrence/conclusion: according to the investigation results, the formation of blood clots was observed in the actual sample; however, no anomalies that could lead to decreasing venous blood flow rate, such as a breakage, was observed in the actual sample.Since no anomaly that could lead to the reported event was observed in the actual sample, the cause in this case could not be clarified.Relevent ifu reference: "do not reduce heparin during circulation.Otherwise, blood clotting might occur.Adequate heparinization of the blood is required to prevent it from clotting in the system." terumo medical products (tmp) (importer) registration no.(b)(6) is submitting this report on behalf of ashitaka factory of terumo corporation (manufacturer) registration no.9681834.
 
Event Description
The user facility reported that during cpb, while using oxygenator as usual, they felt that venous blood flow rate was low.While there were no changes in the pressure loss of the oxygenator and vavd pressure, there was a timing when the venous blood flow decreased, though the drop was less than 1l.It was not serious enough to replace the oxygenator, and they continued using it.The procedure was completed successfully.The patient was not harmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX CUSTOM PACK
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO MEDICAL CORPORATION
950 elkton blvd.
elkton MD 21921
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, 418
JA   418
Manufacturer Contact
gina digioia
265 davidson ave
suite 320
somerset, NJ 08873
6402040886
MDR Report Key17168147
MDR Text Key318012621
Report Number9681834-2023-00101
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K071494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 06/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2024
Device Model NumberN/A
Device Catalogue NumberCX-XRX55003
Device Lot Number221222
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/23/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/22/2023
Initial Date FDA Received06/20/2023
Date Device Manufactured12/22/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-